61 results
Page 2 of 4
8-K
EX-99.2
kn7cx
15 Mar 21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
8:10am
8-K
EX-99.1
mff fds3z2mw3
12 Nov 20
PhaseBio Reports Recent Business Highlights and Third-Quarter 2020 Financial Results
4:12pm
8-K
EX-99.1
obvm sqivrb
23 Oct 20
PhaseBio Provides Pemziviptadil (PB1046) Program Update
8:20am
S-3
EX-1.2
qywb11vanht88 jg
27 Dec 19
Shelf registration
5:28pm
S-3
6czh2o2syxqcqip xj3
27 Dec 19
Shelf registration
5:28pm
S-3
EX-4.2
1hpv 6adg3vlgmciwq
27 Dec 19
Shelf registration
5:28pm
8-K
EX-99.3
rlg3d0d0czkmv ayyc49
14 Aug 19
Regulation FD Disclosure
12:00am
424B4
ohx8xm
12 Apr 19
Prospectus supplement with pricing info
4:32pm
DEF 14A
8gahd4bmbixa3 t01
5 Apr 19
Definitive proxy
4:05pm
DRS
9gkk 2ftg
29 Mar 19
Draft registration statement
12:00am